Manufacturer
Pharmathen S.A.(GREECE)
Registraction Number
MAL24126019ACZ
Content:
Each 5 mL vial contains:
-Levetiracetam: 500 mg
Indications:
-Epilepsy: Used to control epilepsy, including:
-Partial onset seizures with or without secondary generalization in patients aged 4 years and older.
-Myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME).
-Primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).
Instructions:
Dosage: The dosage varies based on the patient's condition and response. It can be initiated with either intravenous or oral administration.
Administration:
-Administer by intravenous infusion after dilution.
-The total daily dose and frequency of administration should be determined by the healthcare provider.
-The infusion should be given slowly to avoid rapid diuresis.